Instrument Inactif

Communiqués Apptix ASA Oslo Bors

Actions

NO0010123060

Equipement et technologie médicale avancés

Communiqués

09/06	Carasent completes the acquisition of Infosolutions	AQ
29/05	Change in the number of shares and votes in Carasent AB (publ)	AQ
27/04	Carasent: Broadening with lab solution in Sweden	AQ
27/04	Carasent: Announces acquisition of Infosolutions	AQ
27/04	Carasent acquires Infosolutions and strengthens its position in Swedish private healthcare	AQ
20/04	Annual General Meeting in Carasent AB (publ)	AQ
15/04	Carasent (Q1 review): Medsum momentum and German milestone	AQ
15/04	Carasent: Focus on recurring revenue – Q1 review	AQ
14/04	Carasent (Q1 initial take): Strong ARR, but profitability below expectations on higher costs and softer consulting	AQ
14/04	Carasent: Miss on headline but recurring revenue strong – Q1 initial	AQ
14/04	Carasent : Q12026 En	PU
14/04	Carasent : Q1 2026 Presentation	PU
14/04	Carasent AB (publ) – interim report Q1 2026	AQ
08/04	Carasent () : Invitation to presentation of Q1 2026 results	PU
08/04	Carasent AB (publ) – Invitation to presentation of Q1 2026 results	AQ
31/03	Carasent: Ticks a lot of boxes in an uncertain environment – Q1 preview	AQ
19/03	Notice of Annual General Meeting in Carasent AB (publ)	AQ
19/03	Carasent : Annual Report 2025	PU
19/03	Carasent publishes Annual Report for 2025	AQ
16/02	Carasent (Q4 review): New products and sales initiatives to drive growth in 2026	AQ
12/02	Carasent: Little to complain about in Q4	AQ
12/02	Carasent: 11%-point Y/Y margin improvement – Q4 initial comment	AQ
12/02	Carasent : Q42025 En	PU
12/02	Carasent : Q4 2025 Presentation	PU
12/02	Carasent AB (publ) – Year-end report January–December 2025	AQ